Slaven Jurković

Prof. Slaven Jurković

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MLMaja Lenartić
Maja Lenartić
VJVedrana Jelenčić
Vedrana Jelenčić
BZBiljana Zafirova
Biljana Zafirova
MOMateja Ozanic
Mateja Ozanic
VMValentina Marecic
Valentina Marecic
BPBojan Polić
Bojan Polić
NKG2D is a potent activating receptor that is expressed on cytotoxic immune cells such as CD8 T and NK cells, where it promotes cytotoxicity after binding stress ligands on infected or transformed cells. On NK cell precursors NKG2D modulates proliferation and maturation. Previously, we observed that NKG2D deficiency affects peripheral B cell numbers. In this study, we show that NKG2D regulates B1a cell development and function. We find that mice deficient for NKG2D have a strong reduction of B1a cell numbers. As a result, NKG2D-deficient mice produce significantly less Ag-specific IgM Abs upon immunization with T cell–independent Ags, and they are more susceptible to Gram-negative sepsis. Klrk1−/− B1a cells are also functionally impaired and they fail to provide protection against Francisella novicida upon adoptive transfer. Using mixed bone marrow chimeric mice, we show that the impact of NKG2D deficiency on B1a cell development is cell intrinsic. No changes in homeostatic turnover and homing of B cells were detectable, limiting the effects of NKG2D to modulation of the hematopoietic development of B1a cells. Using conditional ablation, we demonstrate that the effect of NKG2D on B1a cell development occurs at a developmental stage that precedes the common lymphoid progenitor. Our findings reveal an unexpected new role for NKG2D in the regulation of B1a cell development. The protective effects of this activating receptor therefore reach beyond that of cytotoxic cells, stimulating the immune system to fight bacterial infections by promoting development of innate-like B cells.

1 October 2020 in Physica Medica
Verified
Journal Article
Closed access
DDDea Dundara Debeljuh
Dea Dundara Debeljuh
Slaven JurkovićSlaven Jurković
Slaven Jurković
IPIvan Pribanić
Ivan Pribanić
FPFrano Poljak
Frano Poljak
IKIvana Kralik
Ivana Kralik
JVJenia Vassileva
Jenia Vassileva

8 June 2023 in Physica Medica
Verified
Journal Article
Closed access
IPIvan Pribanić
Ivan Pribanić
SSSrđan Daniel Simić
Srđan Daniel Simić
NTNikola Tankovic
Nikola Tankovic
DDDea Dundara Debeljuh
Dea Dundara Debeljuh
Slaven JurkovićSlaven Jurković
Slaven Jurković

1 November 2021 in Radiography
Verified
Journal Article
Closed access
PZPetra Valkovic Zujic
Petra Valkovic Zujic
ABA. Božanić
A. Božanić
Slaven JurkovićSlaven Jurković
Slaven Jurković
DRDoris Šegota Ritoša
Doris Šegota Ritoša
EDE. Grgurević Dujmić
E. Grgurević Dujmić
MKM. Karić
M. Karić

1 November 2019 in Ultrasonics
Verified
Journal Article
Closed access
GŽGordana Žauhar
Gordana Žauhar
ÐRÐeni Smilović Radojčić
Ðeni Smilović Radojčić
ZKZoran Kaliman
Zoran Kaliman
TSTea Schnurrer-Luke-Vrbanić
Tea Schnurrer-Luke-Vrbanić
Slaven JurkovićSlaven Jurković
Slaven Jurković

1 December 2018 in Medical Dosimetry
Verified
Journal Article
Closed access
ÐRÐeni Smilović Radojčić
Ðeni Smilović Radojčić
MKManda Švabić Kolacio
Manda Švabić Kolacio
MRMilan Radojčić
Milan Radojčić
DRDavid Rajlić
David Rajlić
BCBožidar Casar
Božidar Casar
Slaven JurkovićSlaven Jurković
Slaven Jurković